Labesfal: Investment strategy 2020/22 (Q2908436): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 66.0 percent, Removing co-finance rate from projects in portugal) |
(Removed claim: budget (P474): 5,455,945.54 euro) |
||||||
| Property / budget | |||||||
| |||||||
| Property / budget: 5,455,945.54 Euro / rank | |||||||
Revision as of 16:02, 21 October 2021
Project Q2908436 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Labesfal: Investment strategy 2020/22 |
Project Q2908436 in Portugal |
Statements
21 July 2020
0 references
30 July 2022
0 references
LABESFAL - LABORATÓRIOS ALMIRO S.A.
0 references
40°30'59.11"N, 8°4'49.91"W
0 references
O Projeto tem como objetivo dotar a Labesfal de meios e tecnologias state-of-the-art alinhadas com o paradigma da Indústria 4.0, conducentes ao incremento da sua capacidade produtiva ao nível do fabrico de penicilinas e à capacitação para a produção de bolsas de nutrição parentérica. (Portuguese)
0 references
The project aims to provide Labesfal with state-of-the-art means and technologies aligned with the Industry 4.0 paradigm, leading to increased production capacity in penicillin manufacturing and training for the production of parenteral nutrition bags. (English)
8 July 2021
0 references
Tondela
0 references
Identifiers
POCI-01-0249-FEDER-072212
0 references